Guardant Health, Inc. (GH) DCF Valuation

Guardant Health, Inc. (GH) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Guardant Health, Inc. (GH) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Guardant Health, Inc. (GH) financial prospects like an expert! This (GH) DCF Calculator provides pre-filled financial data along with the flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 214.4 286.7 373.7 449.5 563.9 718.8 916.1 1,167.7 1,488.3 1,896.9
Revenue Growth, % 0 33.75 30.32 20.31 25.45 27.46 27.46 27.46 27.46 27.46
EBITDA -54.9 -225.1 -359.6 -614.9 -433.3 -542.3 -691.1 -880.9 -1,122.8 -1,431.0
EBITDA, % -25.62 -78.5 -96.24 -136.79 -76.83 -75.44 -75.44 -75.44 -75.44 -75.44
Depreciation 13.6 16.1 22.3 36.0 42.9 48.2 61.4 78.3 99.8 127.2
Depreciation, % 6.35 5.6 5.96 8 7.6 6.7 6.7 6.7 6.7 6.7
EBIT -68.5 -241.1 -381.9 -650.9 -476.2 -575.8 -733.9 -935.3 -1,192.2 -1,519.5
EBIT, % -31.97 -84.1 -102.21 -144.79 -84.44 -80.1 -80.1 -80.1 -80.1 -80.1
Total Cash 522.8 1,794.9 932.7 1,011.2 1,168.6 718.8 916.1 1,167.7 1,488.3 1,896.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 48.0 53.3 97.7 97.3 88.8
Account Receivables, % 22.38 18.59 26.13 21.63 15.74
Inventories 15.2 22.7 30.7 51.6 61.9 65.7 83.7 106.7 136.0 173.3
Inventories, % 7.08 7.92 8.21 11.48 10.98 9.14 9.14 9.14 9.14 9.14
Accounts Payable 16.2 7.3 17.6 68.9 51.7 56.5 72.1 91.8 117.1 149.2
Accounts Payable, % 7.56 2.56 4.7 15.33 9.17 7.86 7.86 7.86 7.86 7.86
Capital Expenditure -21.3 -54.1 -75.0 -77.5 -20.5 -100.2 -127.8 -162.8 -207.6 -264.5
Capital Expenditure, % -9.93 -18.85 -20.08 -17.23 -3.63 -13.95 -13.95 -13.95 -13.95 -13.95
Tax Rate, % -0.14308 -0.14308 -0.14308 -0.14308 -0.14308 -0.14308 -0.14308 -0.14308 -0.14308 -0.14308
EBITAT -66.7 -241.5 -382.2 -652.0 -476.9 -572.7 -729.9 -930.3 -1,185.8 -1,511.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -121.3 -301.2 -477.0 -662.7 -473.5 -685.1 -840.0 -1,070.6 -1,364.6 -1,739.3
WACC, % 8.15 8.19 8.19 8.19 8.19 8.18 8.18 8.18 8.18 8.18
PV UFCF
SUM PV UFCF -4,367.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1,774
Terminal Value -28,708
Present Terminal Value -19,377
Enterprise Value -23,744
Net Debt 220
Equity Value -23,964
Diluted Shares Outstanding, MM 112
Equity Value Per Share -213.99

What You Will Get

  • Real GH Financial Data: Pre-filled with Guardant Health’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Guardant Health’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Real-Life GH Data: Pre-filled with Guardant Health’s historical financials and forward-looking projections.
  • Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
  • Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
  • Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
  • User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.

How It Works

  • Step 1: Download the prebuilt Excel template with Guardant Health’s (GH) data included.
  • Step 2: Explore the pre-filled sheets and understand the key metrics relevant to Guardant Health (GH).
  • Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view recalculated results, including Guardant Health’s (GH) intrinsic value.
  • Step 5: Make informed investment decisions or generate reports using the outputs.

Why Choose This Calculator?

  • Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and healthcare consultants.
  • Accurate Data: Guardant Health's historical and projected financials preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth experience.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive valuation models for in-depth analysis of Guardant Health (GH) stock.
  • Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Offer clients precise valuation insights for Guardant Health (GH) and its market position.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech companies like Guardant Health (GH) are valued in the financial landscape.

What the Template Contains

  • Historical Data: Includes Guardant Health's past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Guardant Health's intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Guardant Health's financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.